Beata Szefler

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Molecular Dynamics

Top Venues

International journal of molecular sciences

International journal of nanomedicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kamil Szupryczyński, Przemysław Czeleń, Tomasz Jeliński, Beata Szefler
What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review. International journal of nanomedicine 19 (2024)
Przemysław Czeleń, Tomasz Jeliński, Agnieszka Skotnicka, Beata Szefler, Kamil Szupryczyński
ADMET and Solubility Analysis of New 5-Nitroisatine-Based Inhibitors of CDK2 Enzymes. Biomedicines 11 (11) (2023)
Beata Szefler, Przemysław Czeleń
Will the Interactions of Some Platinum (II)-Based Drugs with B-Vitamins Reduce Their Therapeutic Effect in Cancer Patients? Comparison of Chemotherapeutic Agents such as Cisplatin, Carboplatin and Oxaliplatin-A Review. International journal of molecular sciences 24 (2) (2023)
Beata Szefler, Przemysław Czeleń
Will the Interactions of Some Platinum (II)-Based Drugs with B-Vitamins Reduce Their Therapeutic Effect in Cancer Patients? Comparison of Chemotherapeutic Agents such as Cisplatin, Carboplatin and Oxaliplatin-A Review. International journal of molecular sciences 24 (2) (2023)
Beata Szefler, Przemysław Czeleń
Will the Interactions of Some Platinum (II)-Based Drugs with B-Vitamins Reduce Their Therapeutic Effect in Cancer Patients? Comparison of Chemotherapeutic Agents such as Cisplatin, Carboplatin and Oxaliplatin-A Review. International journal of molecular sciences 24 (2) (2023)
Przemysław Czeleń, Agnieszka Skotnicka, Beata Szefler
Designing and Synthesis of New Isatin Derivatives as Potential CDK2 Inhibitors. International journal of molecular sciences 23 (14) (2022)
Beata Szefler, Przemysław Czeleń, Kamil Wojtkowiak, Aneta Jezierska
Affinities to Oxaliplatin: Vitamins from B Group vs. Nucleobases. International journal of molecular sciences 23 (18) (2022)
Przemysław Czeleń, Beata Szefler
The Oxindole Derivatives, New Promising GSK-3β Inhibitors as One of the Potential Treatments for Alzheimer's Disease-A Molecular Dynamics Approach. Biology 10 (4) (2021)
Beata Szefler, Przemysław Czeleń, Przemysław Krawczyk
The Affinity of Carboplatin to B-Vitamins and Nucleobases. International journal of molecular sciences 22 (7) (2021)